Brett Ritchie

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Edward Gane, Stuart K. Roberts, Catherine AM Stedman et al. · The Lancet · 2010 · 336 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Genetic and Biochemical Characterization of an Acquired Subgroup B3 Metallo-β-Lactamase Gene, <i>bla</i> _AIM-1 , and Its Unique Genetic Context in Pseudomonas aeruginosa from Australia

Dongeun Yong, Mark A. Toleman, Jan Bell et al. · Antimicrobial Agents and Chemotherapy · 2012 · 98 citations · Full text

Life Sciences, Genetics, Microbiology +14

Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C

Rohit Kulkarni, Edward Gane, Stuart K. Roberts et al. · Gastroenterology · 2012 · 91 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

1046 FIRST-IN-MAN DEMONSTRATION OF POTENT ANTIVIRAL ACTIVITY WITH A NUCLEOSIDE POLYMERASE (R7128) AND PROTEASE (R7227/ITMN-191) INHIBITOR COMBINATION IN HCV: SAFETY, PHARMACOKINETICS, AND VIROLOGIC RESULTS FROM INFORM-1

Edward Gane, S. Roberts, Catherine Stedman et al. · Journal of Hepatology · 2009 · 63 citations

Medicine, Infectious Diseases, Pharmacology +14

Efficacy of <i>Lactobacillus</i> GG in Aboriginal Children With Acute Diarrhoeal Disease: A Randomised Clinical Trial

Brett Ritchie, David Brewster, Cuong Tran et al. · Journal of Pediatric Gastroenterology and Nutrition · 2010 · 50 citations

Medicine, Child Health, Pediatrics +17